TGFβ-1 and the development of chronic graft nephropathy: Relative roles of gene, mRNA and protein

Annals of the Royal College of Surgeons of England

Volumn 87, Issue 5, 2005, Pages 326-330

  Morris Stiff, Gareth ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

Author keywords

Chronic graft nephropathy; Renal transplantation; TGF 1

Indexed keywords

MESSENGER RNA; PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CADAVER KIDNEY; CHRONIC ALLOGRAFT NEPHROPATHY; GENETIC POLYMORPHISM; HUMAN; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; NON INVASIVE MEASUREMENT; NONHUMAN; PROTEIN EXPRESSION; CHRONIC DISEASE; GENETICS; GRAFT REJECTION; KIDNEY DISEASE; METABOLISM; PHYSIOLOGY; REVIEW;

CHRONIC DISEASE; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POLYMORPHISM, GENETIC; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 28844474993     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588405X60533     Document Type: Article

References (32)

1. UK Transplant. Renal Transplant Audit 1990-1998. London: UK Transplant, 2001.
2. Paul LC, Häyry P, Foegh M et al. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants. Joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Atherosclerosis in Transplanted Organs. Transplant Proc 1993; 25: 2022-3.
3. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-22.
4. Beckingham IJ, O'Rourke JS, Stubington SR, Hinwood M, Bishop MC, Rigg KM. Impact of cyclosporin on the incidence and prevalence of chronic rejection in renal transplants. Ann R Coll Surg Engl 1997; 79: 138-42.
5. Kirkman RL, Strom TB, Weir MR, Tilney NL. Late mortality and morbidity in recipients of long term allografts. Transplantation 1982; 34: 347-51.
6. Isoniemi HM, Krogerus L, von Willebrand E et al. Histological findings in well-functioning, long-term renal allografts. Kidney Int 1992; 41: 155-60.
7. Solez K, Vincenti F, Flio RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus and cyclosporine. Transplantation 1998; 66: 1736-40.
8. Rush DN, Henry SF, Jeffrey JR, Schroeder TJ, Gough J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57; 208-11.
9. Rush DN, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: a randomised study. J Am Soc Nephrol 1998; 9: 2129-34.
10. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor. Proc Natl Acad Sci USA 1981; 78: 5339-43.
11. Moses HL, Branum EL, Proper JA, Robinson RA. Transforming growth factor production by chemically transformed cells. Cancer Res 1981; 41: 2842-8.
12. Derynck R, Jarrett JA, Chen EY, Goedel DV et al. The murine transforming growth factor-b complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701-5.
13. Fujii D, Brissenden J, Derynck R, Franke U. Transforming growth factor-β gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet 1986; 12: 281-8.
14. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6: 597-641.
15. Wahl SM, McCartney-Francis NM, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGFβ. Immunol Today 1989; 10: 258-61.
16. Sporn MB, Roberts AB. Autocrine secretion - 10 years later. Ann Intern Med 1992; 117: 408-14.
17. Coupes BM, Newstead CG, Short CD, Brenchley PE. Transforming growth factor β1 in renal allograft recipients. Transplantation 1994; 57: 1727-31.
18. Coupes BM, Williams S, Roberts ISD et al. Differential expression of TGFβ during immunosuppression with tacrolimus and cyclosporine A (CsA) in human renal allograft recipients [Abstract]. ASN 1999: A3668.
19. Horvath LS, Friess H, Schilling M et al. Altered expression of transforming growth factor-βs in chronic renal rejection. Kidney Int 1996; 50: 489-98.
20. Shihab FS, Yamamoto T, Nast CC et al. Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 1995; 62: 286-94.
21. Pilmore H, Eris J, Painter D, Tiller D, Bishop A, McLaughlon G. Expression of growth factors in chronic renal allograft rejection [Abstract]. Transplantation Society 1998.
22. Iñigo P, Palacin A, Campistol JM et al. Differences between acute and chronic renal graft rejection on immunohistochemical staining of transforming growth factor beta-1. Transplant Proc 1999b; 31: 2309-10.
23. Cuhaci B, Kumar MSA, Bloom RD et al. Transforming growth factor-β levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 1999; 68: 785-90.
24. Gaciong Z, Koziak K, Religa P et al. Increased expression of growth factors during chronic rejection of human kidney allograft. Transplant Proc 1995: 27: 928-29.
25. Sharma VK, Bologa RM, Xu G-P et al. Intragraft TGF-β1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996; 49: 1297-303.
26. Vuillemin T, Legendre G, Meduri G et al. Chronic rejection and cell growth factors. Transplant Proc 1996; 28: 2831-2.
27. Nicholson ML, Bicknell GR, Barker G, Doughman TM, William ST, Furness PN. Intragraft expression of transforming growth factor β1 gene in isolated glomeruli from human renal transplants. Br J Surg 1999; 86: 1144-8.
28. Bicknell GR, Williams ST, Shaw JA, Pringle JM, Furness PN, Nicholson ML. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br J Surg 2000; 87: 1569-75.
29. Iñigo P, Lario S, Campistol JM, Oppenheimer F, Rivera F. Relation between transforming growth factor β1 (TGFβ) gene polymorphisms and the development of chronic allograft nephropathy in renal transplant (RT) recipients [Abstract]. ESOT 1999.
30. Williams S, Watson CJ, Coupes BM et al. Association of TGFβ1 gene polymorphisms with in vivo plasma TGFβ1 expression and chronic vascular rejection (CVR) in renal transplant recipients [Abstract]. ASN 1999: A3884
31. Haldar NA, McLaren A, Marshall SE, Morris PJ, Welsh KI. Is renal graft survival predetermined by the recipient's cytokine profile? Transplant Proc 1991; 31: 289-90.
32. McNamee PT, Connolly JK, Middleton D, Feeney SA, Savage DA, Maxwell AP. Transforming growth factor (TGF-β1) gene variants do not influence renal allograft survival [Abstract]. ASN 1999: A3730